SciBase and Skin and Cancer Institute partner to advance AI-driven skin cancer detection in California

„We are excited to integrate the Nevisense test during routine skin exams in several of our California offices and offer our patients the latest AI-driven technology for the earliest possible detection of melanoma.  Melanoma is the deadliest form of skin cancer, but when detected early, treatment has a nearly 100% cure rate.  Early testing and… SciBase and Skin and Cancer Institute partner to advance AI-driven skin cancer detection in California weiterlesen

Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2024

Thomas Axelsson (Gell Group), Dharminder Chahal (VanHerk Group), Peter Elmvik (Stockholms Elbolag), Tord Lendau (Chairman of the Board). The appointments have been made in accordance with the instructions regarding principles for the appointment of the company nominating committee which were determined at the Annual General Meeting of SciBase Holding on May 17, 2023. The Annual… Nomination Committee appointed for SciBase Holding’s Annual General Meeting in 2024 weiterlesen

Nevisense detects skin barrier damage from skin models in research

Skin barrier research comprises one of the fastest-growing fields within the dermatology community, including the development of new therapeutics, testing cosmetics, and beauty products, testing other consumer goods, and the scientific investigation of diseases related to the skin barrier. Nevisense and its underlying Electrical Impedance Spectroscopy (EIS) technology were used to assess the effect of… Nevisense detects skin barrier damage from skin models in research weiterlesen

Nevisense detects skin barrier dysfunction in children with Atopic Dermatitis

Atopic Dermatitis is one of the most prevalent disorders in the world, affecting up to 20% of children globally. Currently, there is no clinical device that can assist in the diagnosis or severity assessment of AD.   The study was performed on children between 4 months and 3 years of age and aimed at identifying… Nevisense detects skin barrier dysfunction in children with Atopic Dermatitis weiterlesen

SciBase initiates pilot with Bare Dermatology to advance skin cancer detection in Texas

„At Bare Dermatology, we strive to provide our patients with the highest standard of care. Nevisense can help us to identify melanoma at an early stage, which is critical for improving patient outcomes. Melanoma is a leading cause of death among skin cancers, but when detected early, it has a nearly 100% cure rate. Our… SciBase initiates pilot with Bare Dermatology to advance skin cancer detection in Texas weiterlesen

SciBase strengthens US team with experienced Dermatology executive

Dan was previously Senior Director Commercial Insights, Market Access and Field Reimbursement at Biofrontera Inc., a company focused on the Dermatology market treating actinic keratosis with PDT (Photodynamic Therapy). At Biofrontera Inc., Dan was an instrumental leader in launching the new company in the US market with their first FDA approved drug and device combination… SciBase strengthens US team with experienced Dermatology executive weiterlesen

SciBase appoints Pia Renaudin as Chief Executive Officer

Pia will join SciBase as CEO on October 1st, 2023. As previously announced on May 15th, Simon Grant resigned from his position as CEO for personal reasons and will remain with the Company until the end of October to fully support the transition.  Pia is an exceptionally well-suited candidate to implement SciBase’s strategy in order… SciBase appoints Pia Renaudin as Chief Executive Officer weiterlesen

Letter from the Chairman of the Board

SciBase has, under Simons leadership, built a foundation for growth by developing two dermatology products with great potential. Many important advancements have been made within the research, development, quality, regulatory, initial sales, and the reimbursement sides of the business. I believe we now have a solid foundation to stand on and, as Simon will remain… Letter from the Chairman of the Board weiterlesen

Clarification regarding announcement of senior management changes in SciBase

The Board has initiated the process to recruit a new CEO and will provide an update in due course. Tord Lendau, chairman of the board of SciBase, will take over certain operational parts of the role of CEO during the transition period as Simon Grant will gradually reduce his involvement. As chairman of the board,… Clarification regarding announcement of senior management changes in SciBase weiterlesen

SciBase announces changes in senior management

The Board has initiated the process to recruit a new CEO and will provide an update in due course. Tord Lendau, Chairman of the Board of Directors of SciBase, will assume the role of CEO in the interim to ensure a smooth transition. „We thank Simon for his efforts as Managing Director at SciBase. During… SciBase announces changes in senior management weiterlesen

Besucheradresse